Are CRH & NGF as psychoneuroimmune regulators in women with polycystic ovary syndrome?

References

• Mortada R, Williams T. Metabolic syndrome: polycystic ovary syndrome. FP Essent 2015;435:30–42
   PubMedGoogle Scholar
• Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health 2011;3:25–35
   PubMedGoogle Scholar
• Egan BM. Insulin resistance and the sympathetic nervous system. Curr Hypertens Rep 2003;5:247–54
   PubMed Web of Science ®Google Scholar
• dos Santos Moreira MC, de Jesus Pinto IS, Mourão AA, et al. Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome? Front Physiol 2015;6:234
   PubMed Web of Science ®Google Scholar
• Thorp AA, Schlaich MP. Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. J Diabetes Res 2015;2015:341583
   PubMed Web of Science ®Google Scholar
• Rahmouni K, Morgan DA, Morgan GM. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Investig 2004;114:652–8
   PubMed Web of Science ®Google Scholar
• Flaa A, Aksnes TA, Kjeldsen SE. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metab Clin Exp 2008;57:1422–7
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998;16:457–99
   PubMedGoogle Scholar
• Reis FM, Cobellis L, Luisi S, et al. Paracrine/autocrine control of female reproduction. Gynecol Endocrinol 2000;14:464–75
   PubMed Web of Science ®Google Scholar
• Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 2009;10:397–409
   PubMed Web of Science ®Google Scholar
• Kiapekou E, Zapanti E, Mastorakos G, Loutradis D. Update on the role of ovarian corticotropin-releasing hormone. Ann N Y Acad Sci 2010;1205:225–9
   PubMed Web of Science ®Google Scholar
• Kalantaridoua SN, Makrigiannakisb M, Zoumakisc E, Chrousosc GP. Stress and the female reproductive system. J Reprod Immunol 2004;62:61–8
   PubMed Web of Science ®Google Scholar
• Mastorakos G, Karoutsou EI, Mizamtsidi M. Corticotropin releasing hormone and the immune/inflammatory response. Eur J Endocrinol 2006;155:S77–84
   Google Scholar
• Zangeneh FZ. Stress and female reproductive system: disruption of corticotropin-releasing hormone/opiate balance by sympathetic nerve traffic. J Fam Reprod Health 2009;3:69–76
   Google Scholar
• Cohen S. Origins of growth factors: NGF and EGF. J Biol Chem 2008;283:33793–7
   PubMed Web of Science ®Google Scholar
• Aloe L, Maria Luisa Rocco ML, Bianchi P, Manni L. Nerve growth factor: from the early discoveries to the potential clinical use. J Transl Med 2012;10:239
   PubMed Web of Science ®Google Scholar
• Stepanichev M, Dygalo NN, Grigoryan G, et al. Rodent models of depression: neurotrophic and neuroinflammatory biomarkers. Biomed Res Int 2014;2014:932757
   PubMed Web of Science ®Google Scholar
• Chen YW, Lin PY, Tu KY, et al. Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review. Neuropsychiatr Dis Treat 2015;11:925–33
   PubMed Web of Science ®Google Scholar
• Wiener CD, de Mello Ferreira S, Pedrotti Moreira F, et al. Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk. J Affect Disord 2015;184:245–8
   PubMed Web of Science ®Google Scholar
• Freeman RS, Burch RL, Crowder RJ, et al. NGF deprivation-induced gene expression: after ten years, where do we stand? Prog Brain Res 2004;146:111–26
   PubMed Web of Science ®Google Scholar
• Lawrence IE, Jr, Burden HW. The origin of the extrinsic adrenergic innervations to the rat ovary. Anat Rec 1980;196:51–9
   PubMedGoogle Scholar
• Mayerhofer A, Smith GD, Danilchik M, et al. Oocytes are a source of catecholamines in the primate ovary: evidence for a cell-cell regulatory loop. Proc Natl Acad Sci USA 1988;95:10990–5
   Web of Science ®Google Scholar
• Stener-Victorin E, Ploj K, Larsson BM, Holmäng A. Rats with steroid-induced polycystic ovaries develops hypertension and increased sympathetic nervous system activity. Reprod Biol Endocrinol 2005;53:44
   Web of Science ®Google Scholar
• Lansdown A, Rees DA. The sympathetic nervous system in polycystic ovary syndrome a novel therapeutic target? Clin Endocrinol 2012;77:791–801
   PubMed Web of Science ®Google Scholar
• Vizi ES, Elenkov IJ. Nonsynaptic noradrenaline release in neuro-immune responses. Acta Biol Hung 2002;53:229–44
   PubMed Web of Science ®Google Scholar
• Gérard N, Caillaud M, Martoriati A, et al. The interleukin-1 system and female reproduction. J Endocrinol 2004;180:203–12
   PubMed Web of Science ®Google Scholar
• Dantzer R. Cytokine-induced sickness behavior: where do we stand? Brain BehavImmun 2001;15:7–24
   Web of Science ®Google Scholar
• Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007;21:153–60
   PubMed Web of Science ®Google Scholar
• Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am 2009;29:247–64
   PubMed Web of Science ®Google Scholar
• Myers JS. Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms. Oncol Nurs Forum 2008;35:802–7
   PubMed Web of Science ®Google Scholar
• Mansson M, Holte J, Landin-Wilhelmsen K, et al. Women with polycystic ovary syndrome are often depressed or anxious – a case control study. Psychoneuroendocrinology 2008;33:1132–8
   PubMed Web of Science ®Google Scholar
• Veltman-Verhulst SM, Boivin J, Eijkemans MJ, Fauser BJ. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update 2012;18:638–51
   PubMed Web of Science ®Google Scholar
• Zangeneh FZ, Naghizadeh MM, Abedinia N, et al. Psychological signs in patients with polycystic ovary syndrome. J Fam Reprod Health 2012;6:145–51
   Google Scholar
• Zangeneh FZ, Naghizadeh MM, Abdollahi A, Bagheri M. Synchrony between ovarian function & sleep in polycystic ovarysyndrome patients. Open J Obstet Gynecol 2014;4:725–31
   Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored. PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
   Web of Science ®Google Scholar
• Mastorakos G, Scopa CD, Vryonidou A, et al. Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic ovaries. J Clin Endocrinol Metab 1994;79:934–9
   PubMed Web of Science ®Google Scholar
• Zoumakis E, Chatzaki E, Charalampopoulos I, et al. Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries. Gynecol Endocrinol 2001;15:98–102
   PubMed Web of Science ®Google Scholar
• Asakura H, Zwain IH, Yen SS. Expression of genes encoding corticotropin-releasing factor (CRF), type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary. J Clin Endocrinol Metab 1997;82:2720–5
   PubMed Web of Science ®Google Scholar
• Valentino RJ, Page M, Van Bockstaele E, Aston-Jones G. Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input. Neuroscience 1992;48:689–705
   PubMed Web of Science ®Google Scholar
• Jedema HP, Gracel AA. Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J Neurosci 2004;24:9703–13
   PubMed Web of Science ®Google Scholar
• McCall JG, Al-Hasani R, Siuda ER, et al. CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety. Neuron 2015;5:605–20
   Web of Science ®Google Scholar
• Sun Y, Hunt S, Sah P. Norepinephrine and corticotropin-releasing hormone: partners in the neural circuits that underpin stress and anxiety. Neuron 2015;87:468–70
   PubMed Web of Science ®Google Scholar
• Mello A, Mello MF, Carpenter LL, Price LH. Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis. Rev Bras Psiquiatr 2003;25:231–8
   PubMedGoogle Scholar
• Aloe L, Alleva E, Fiore M. Stress and nerve growth factor: findings in animal models and humans. Pharmacol Biochem Behav 2002;73:159–66
   PubMed Web of Science ®Google Scholar
• Kerr B, Garcia-Rudaz C, Dorfman M, et al. NTRK1 and NTRK2 receptors facilitate follicle assembly and early follicular development in the mouse ovary. Reproduction 2009;138:131–40
   PubMed Web of Science ®Google Scholar
• Dorfman MD, Garcia-Rudaz C, Alderman Z, et al. Loss of Ntrk2/Kiss1r signaling in oocytes causes premature ovarian failure. Endocrinology 2014;155:3098–111
   PubMed Web of Science ®Google Scholar
• Heider U, Pedal I, Spanel-Borowski K. Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries. Fertil Steril 2001;75:1141–7
   PubMed Web of Science ®Google Scholar
• Chaldakov G. The metabotrophic NGF and BDNF: an emerging concept. Arch Ital Biol 2011;149:257–63
   PubMed Web of Science ®Google Scholar
• Ali TK, Al-Gayyar MM, Matragoon S. Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury. Diabetologia 2011;54:657–68
   PubMed Web of Science ®Google Scholar
• Cirulli F, Alleva E. The NGF saga: from animal models of psychosocial stress to stress-related psychopathology. Front Neuroendocrinol 2009;30:379–95
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang T, He S. Nerve growth factor variations in patients with mood disorders: no changes in eight weeks of clinical treatment. Neuropsychiatr Dis Treat 2014;10:835–40
   PubMed Web of Science ®Google Scholar
• Faure J, Uys JD, Marais L, et al. Early maternal separation followed by later stressors leads to dysregulation of the HPA-axis and increases in hippocampal NGF and NT-3 levels in a rat model. Metab Brain Dis 2006;21:181–8
   PubMed Web of Science ®Google Scholar
• Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001;49:391–404
   PubMed Web of Science ®Google Scholar
• Aisa B, Gil-Bea FJ, Marcos B. Neonatal stress affects vulnerability of cholinergic neurons and cognition in the rat: involvement of the HPA axis. Psychoneuroendocrinology 2009;34:1495–505
   PubMed Web of Science ®Google Scholar
• Berry A, Bindocci E, Alleva E. NGF, brain and behavioral plasticity. Neural Plast 2012;2012:784040
   PubMed Web of Science ®Google Scholar
• Qiao H, Li MX, Xu C, et al. Dendritic spines in depression: what we learned from animal models. Neural Plasticity 2016;2016:26. Article ID 8056370, pages
   Web of Science ®Google Scholar
• Elenkov IJ, Webster EL, Torpy DJ, Chrousos GP. Stress, corticotrophin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann NY Acad Sci 1999;876:1–11 (discussion 11-3)
   PubMed Web of Science ®Google Scholar
• Milutinović DV, Macut D, Božić I, et al. Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2011;119:636–43
   PubMed Web of Science ®Google Scholar
• Lanzone A, Petraglia F, Fulghesu AM, et al. Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome. Fertil Steril 1995;63:1195–9
   PubMed Web of Science ®Google Scholar
• Rivest S, Rivier C. The role of corticotropin-releasing factor and interleukin-1 in the regulation of neurons controlling reproductive functions. Endocr Rev 1995;16:177–99
   PubMed Web of Science ®Google Scholar
• Guzmán C, Hernández-Bello l, Morales-Montor J. Regulation of steroidogenesis in reproductive, adrenal and neural tissues by cytokines. Open Neuroendocrinol J 2010;3:161–9
   Google Scholar
• Oakley RH, Cidlowski JA. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol 2013;132:1033–44
   PubMed Web of Science ®Google Scholar
• Murray CL, Obiang P, Bannerman D, Cunningham C. Endogenous IL-1 in cognitive function and anxiety: a study in IL-1RI-/- mice. PLoS One 2013;8:e78385
   Google Scholar
• Hoge EA, Brandstetter K, Moshier S, et al. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety 2009;26:447–55
   PubMed Web of Science ®Google Scholar
• Maes M, Bosmans E, Meltzer HY, et al. Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry 1993;150:1189–93
   PubMed Web of Science ®Google Scholar
• Kubera M, Obuchowicz E, Goehler L, et al. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuro Psycho Pharmaco Bio Psychiatry 2011;35:744–59
   PubMed Web of Science ®Google Scholar
• Stromnes IM, Cerretti LM, Liggitt D, et al. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med 2008;14:337–42
   PubMed Web of Science ®Google Scholar
• Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2011;26:2442–51
   PubMed Web of Science ®Google Scholar
• Dokras A, Clifton S, Futterweit W, Wild R. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 2012;97:225–30
   PubMed Web of Science ®Google Scholar